Dr Sean Lim, based at the Centre for Cancer Immunology, has led new research that shows the weakened immune systems of blood cancer patients can improve after they receive a third COVID-19 vaccination.
Patients with lymphoma have defects in their immunity system that restrict its response to vaccination. The Prospective Observational Study Evaluating COVID-19 Vaccine Immune Responses in Lymphoid Cancer (PROSECO) trial launched last year to evaluate immune responses in patients with lymphoid cancers to COVID-19 vaccines.
Results, published in the journal Nature Cancer, found improvements in antibody and T-Cell responses after a third vaccine dose, except in patients who had recently received a certain antibody treatment for their cancer.
Read more on the main University of Southampton website.